We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.


Multi-Genome Analysis Industry Session Features Don Gregory of GenomeQuest

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Multi-Genome Analysis Industry Session Features Don Gregory of GenomeQuest"

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Read time:
GenomeQuest has announced that the session "State-of-the-Art in Whole- and Multi-Genome Analysis: a Discussion and Demonstration of Critical Requirements" at the Next-Generation Sequencing Data Management conference will feature Dr. Don Gregory, head of field application science at GenomeQuest.

The luncheon session starts at 12:40 p.m. on Wednesday, September 29, 2010 at the Rhode Island Convention Center in Providence, RI. The dates for the full conference, run by Cambridge Healthtech Institute, are September 27-29.

In his presentation, Dr. Gregory will outline use cases for multi-genome analysis (MGA), including Family Genetics, Disease/Normal Study, Population Genetics, Pharmacogenomics, and Propensity/Diagnostics.

He will also explore powerful science questions enabled by MGA, including:

• How prevalent is this variation?
• What is the predicted effect of this variation?
• How can I prioritize the observed variations?
• What are the variations common to my triad?
• Is this haplotype generalizable to the overall population?
• Is the variation homozygous/heterozygous?
Lastly, he will review and demonstrate critical requirements of MGA solutions, including:

• Scalability to whole-genome reads
• Interactive querying of sequence comparison results
• Incorporation of custom annotated reference genomes
• Comparison against multiple, very large datasets
• Integrated access to aggregated, public datasets
• Consolidation of multiple comparison results into one virtual, queryable database
• Statistical analysis of clinical attributes
• Visualization of MGA variations
• Detection of structural variation
• Web-enabled, high-performance, openness